DeepSeek’s latest flagship model, V4, has renewed debate over the trajectory of the US-China AI race, with analysts and industry voices suggesting that China’s progress in model efficiency is not translating into a meaningful reduction in capability gaps with leading US systems.

Amid rising global cancer rates and a shortage of pathology staff, Taiwan-based AetherAI says its FDA- and IVDR-certified digital pathology platform could ease diagnostic bottlenecks worldwide by enabling integrated AI tools and automated workflows, potentially accelerating access to faster, scalable cancer diagnostics across hospitals, healthcare systems, and clinics globally.

GrandTech Chairman Frankie Hsu highlighted the company’s successful transformation from a software agency to a dual-engine growth model, powered by its investment in GrandTech Cloud Services (GCS) and its 3D printing business. The former capitalizes on the booming cloud and AI wave, while the latter taps into expanding drone opportunities, providing strong and sustainable momentum.

China’s domestic GPU developer Moore Threads is shifting from heavy R&D spending to early monetisation, delivering triple-digit revenue growth in 2025 and its first quarterly profit in early 2026, driven by rising AI compute demand.